Document is current
Any future updates will be listed below
-
Authors
Iriyama, Noriyoshi https://orcid.org/0000-0001-9176-1988
Nakayama, Hitomi
Nakagawa, Masaru
Takahata, Atsushi
Sato, Eriko
Takano, Motoki
Okada, Keigo
Toyama, Kohtaro
Hayashi, Toshiaki
Abe, Takashi
Tanaka, Keisuke
Senpuku, Yasuhiko
Osada, Yuki
Watanabe, Junichi
Yamamoto, Koh
Sekiguchi, Yasunobu
Oshikawa, Gaku
Kimura, Yuta
Tokuhira, Michihide
Suzuki, Ken
Kumagai, Takashi
Ikezoe, Takayuki
Toyota, Shigeo
Miura, Katsuhiro
Nakazato, Tomonori
Mori, Takehiko
- License Information
-
More Information
Article History
Received: 14 July 2025
Revised: 29 October 2025
Accepted: 5 November 2025
First Online: 9 November 2025
Declarations
:
: Noriyoshi Iriyama received honoraria and speaker fees from Novartis Pharma, Pfizer, Ono Pharmaceutical, Otsuka Pharmaceutical, AbbVie GK, Nippon Shinyaku, Chugai Pharmaceutical, Janssen Pharmaceutical, Meiji Seika Pharma, and Asahi Kasei Pharma. Hitomi Nakayama received honoraria from Sanofi and Janssen Pharmaceutical. Masaru Nakagawa received honoraria from Chugai Pharmaceutical, Janssen Pharmaceutical, Sanofi, Novartis Pharma, Ono Pharmaceutical, AbbVie GK, Takeda Pharmaceutical, Asahi Kasei Pharma, AstraZeneca K.K, and Daiichi Sankyo Company. Atsushi Takahata received honoraria from Janssen Pharmaceutical, Bristol Myers Squibb, and Sanofi. Eriko Sato received honoraria from Janssen Pharmaceutical, Pfizer, Ono Pharmaceutical, and Sanofi. Kohtaro Toyama received honoraria from Novartis Pharma, AbbVie GK, Chugai Pharmaceutical, Sanofi, Ohara Pharmaceutical, and AstraZeneca K.K. Toshiaki Hayashi received honoraria from Janssen Pharmaceutical, Sanofi, Bristol Myers Squibb, and Ono Pharmaceutical. Yuki Osada received honoraria from Janssen Pharmaceutical. Junichi Watanabe received honoraria from Janssen Pharmaceutical, Sanofi, Bristol Myers Squibb, Pfizer, Fujimoto Pharmaceutical, Ono Pharmaceutical, and Takeda Pharmaceutical. Yasunobu Sekiguchi received honoraria from Chugai Pharmaceutical and AbbVie GK. Gaku Oshikawa received honoraria from Janssen Pharmaceutical KK, Bristol Myers Squibb, Takeda Pharmaceutical, Pfizer, Ono Pharmaceutical, Chugai Pharmaceutical, Sanofi, and Towa Pharmaceutical. Michihide Tokuhira received honoraria from Janssen Pharmaceutical, Bristol Myers Squibb, and Sanofi. Ken Suzuki received honoraria from Bristol Myers Squibb, Novartis Pharma, Takeda Pharmaceutical, and Ono Pharmaceutical. Takashi Kumagai received honoraria from Janssen Pharmaceutical KK, Bristol Myers Squibb, Novartis Pharma, Takeda Pharmaceutical, Pfizer, and Ono Pharmaceutical, and honoraria and research funds from Chugai Pharmaceutical. Katsuhiro Miura received honoraria and speaker fees from Chugai Pharmaceutical, Janssen Pharmaceutical, Nippon Shinyaku, AstraZeneca, AbbVie GK, Daiichi Sankyo, Kyowa Kirin, Novartis Pharma, Takeda Pharmaceuticals, Ono Pharmaceutical, and Bristol Myers Squibb. Takehiko Mori received honoraria from Janssen Pharmaceutical, Sanofi, Bristol Myers Squibb, Pfizer, Fujimoto Pharmaceutical, Ono Pharmaceutical, and Takeda Pharmaceutical. The remaining authors declare no conflicts of interest regarding this manuscript.
